Contact
searchSearch
HMP Global
In-stent restenosis

Treat the Mechanism First: Preparing Recurrent ISR for Drug-Coated Balloon Therapy

Related Content

Clinical Trials
Phase III Lp(a)HORIZON: Pelacarsen (Novartis) Reduces Lp(a), Not Cardiovascular Events
09/08/2026
Although lower Lp(a) levels were observed with pelacarsen, the findings did not demonstrate that this translated into reduced cardiovascular risk in the overall study population.
Although lower Lp(a) levels were observed with pelacarsen, the findings did not demonstrate that this translated into reduced cardiovascular risk in the overall study population.
Although lower Lp(a) levels were...
09/08/2026
Cath Lab Digest
2027 ASC Payments
ASCA Demands That CMS Address ASC Payment Cuts in 2027 Proposed Rule
09/03/2026
CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...
CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...
CMS estimates that aggregate...
09/03/2026
Cath Lab Digest
Risk Reduction
Statins in Reducing Events in the Elderly (STAREE) Trial: Statins Reduce Heart Attack and Stroke Risk in Older People By 30 Percent
09/01/2026
A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years. 
A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years. 
A world-first clinical trial...
09/01/2026
Cath Lab Digest
Coronary CT
Independent Oxford-Led Data Showcase Value of Coronary Inflammation Assessment in Non-Contrast Cardiac CT, Identifying Risk Even in Patients With Zero Coronary Calcium
09/01/2026
MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...
MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...
MUNICH -- Caristo...
09/01/2026
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

TAVR: CMS NCD
Joint Statement from ACC, STS, and SCAI on the Transcatheter Aortic Valve Replacement National Coverage Determination
09/11/2026
WASHINGTON—The American College of Cardiology (ACC),  The Society of Thoracic Surgeons (STS), and the Society for Cardiovascular Angiography and Interventions (SCAI), released the following joint statement on the transcatheter aortic valve...
WASHINGTON—The American College of Cardiology (ACC),  The Society of Thoracic Surgeons (STS), and the Society for Cardiovascular Angiography and Interventions (SCAI), released the following joint statement on the transcatheter aortic valve...
WASHINGTON—The American College...
09/11/2026
Cath Lab Digest
TAVR: CMS NCD
Edwards Lifesciences Comments on TAVR National Coverage Decision
09/11/2026
Edwards Lifesciences issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare & Medicaid Services (CMS).
Edwards Lifesciences issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare & Medicaid Services (CMS).
Edwards Lifesciences issued the...
09/11/2026
Cath Lab Digest
ECG + AI
New AI ECG Model Detects Acute MI With Fewer Labeled Examples
09/09/2026
The new tool, called ECG-CLIP, was trained using over 1.7 million ECGs collected from more than 540,000 people and paired with clinicians’ notes, embedding the tool with knowledge that may make it more adaptable for different disease...
The new tool, called ECG-CLIP, was trained using over 1.7 million ECGs collected from more than 540,000 people and paired with clinicians’ notes, embedding the tool with knowledge that may make it more adaptable for different disease...
The new tool, called ECG-CLIP,...
09/09/2026
Cath Lab Digest
Clinical Trials
Phase III Lp(a)HORIZON: Pelacarsen (Novartis) Reduces Lp(a), Not Cardiovascular Events
09/08/2026
Although lower Lp(a) levels were observed with pelacarsen, the findings did not demonstrate that this translated into reduced cardiovascular risk in the overall study population.
Although lower Lp(a) levels were observed with pelacarsen, the findings did not demonstrate that this translated into reduced cardiovascular risk in the overall study population.
Although lower Lp(a) levels were...
09/08/2026
Cath Lab Digest
2027 ASC Payments
ASCA Demands That CMS Address ASC Payment Cuts in 2027 Proposed Rule
09/03/2026
CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...
CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...
CMS estimates that aggregate...
09/03/2026
Cath Lab Digest
ViV TAVR
Medtronic Announces Strategic Investment in Pi-Cardia to Accelerate Innovation for Complex TAVR
09/02/2026
Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.
Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.
Pi-Cardia's ShortCut™ device is...
09/02/2026
Cath Lab Digest
Medicare Reimbursement
CMS Approves New Technology Add-on Payment for Reflow Medical’s Spur® Peripheral Retrievable Stent System
09/01/2026
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1,...
09/01/2026
Vascular Disease Management
Risk Reduction
Statins in Reducing Events in the Elderly (STAREE) Trial: Statins Reduce Heart Attack and Stroke Risk in Older People By 30 Percent
09/01/2026
A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years. 
A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years. 
A world-first clinical trial...
09/01/2026
Cath Lab Digest
Coronary CT
Independent Oxford-Led Data Showcase Value of Coronary Inflammation Assessment in Non-Contrast Cardiac CT, Identifying Risk Even in Patients With Zero Coronary Calcium
09/01/2026
MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...
MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...
MUNICH -- Caristo...
09/01/2026
Cath Lab Digest
Heart Failure
New Treatment Administered During Balloon Angioplasty May Reduce the Risk of Heart Failure After a Heart Attack
09/01/2026
Many people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala University are now presenting a new type of biological treatment that is administered directly...
Many people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala University are now presenting a new type of biological treatment that is administered directly...
Many people who survive a heart...
09/01/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use